Clinical Trial

Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-09-05; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2025-12-01
Trial Details
NCT Number NCT06026943
Lead Sponsor Alpha Tau Medical LTD.
Conditions Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma
Enrollment 15 participants
Start Date 2026-05-06
Primary Completion 2027-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-16